Carta Healthcare provides AI-powered clinical data abstraction solutions to automate data collection and analysis for healthcare organizations.

Abcuro, Inc. is a biotechnology company developing therapies for autoimmune diseases and cancer, with a focus on their lead candidate, ulviprubart, a monoclonal antibody for treating inclusion body myositis.

Rippl is a virtual dementia care company focused on providing tech-driven care solutions and expanding its network of healthcare providers for senior-focused behavioral health.

ROME Therapeutics is a biotechnology company that develops breakthrough medicines for serious diseases, with a focus on an inhibitor of LINE-1 reverse transcriptase for autoimmune diseases, using their proprietary data science platform to identify active repeat elements and assess their roles in disease.